Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1293 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

PharmaMar initiates solid tumour drug study

PM060184, which is a marine-derived, synthetically-produced compound, had demonstrated strong in vitro and in vivo antitumour activity and a favourable safety profile in preclinical toxicology studies. The trials

Particle Sciences, HORIBA form strategic alliance

As per the alliance, HORIBA’s full array of instruments and systems for applications ranging from automotive R&D, process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing and metrology,